Bryan Jaimie, Issa Reda, Bakall Benjamin, Welch Matthew, Bryan J Shepard
University of Florida College of Medicine, Gainesville, FL, USA.
Associated Retina Consultants, Phoenix, AZ, USA.
J Vitreoretin Dis. 2020 Nov 3;5(1):60-65. doi: 10.1177/2474126420962645. eCollection 2021 Jan-Feb.
This case series describes the nature and frequency of retinal manifestations in patients with incontinentia pigmenti (IP).
This is a retrospective single-center case series of all known patients with IP who presented to Associated Retina Consultants (Phoenix, AZ) between May 2016 and April 2019. Twenty-eight eyes of 14 patients with a dermatologic diagnosis of IP were included (n = 28). Most patients underwent examination under anesthesia with fundus photographs and intravenous fluorescein angiography (IVFA).
Of the 28 eyes, 8 (28.6%) had abnormal retinal findings on fundus examination. Of the 26 eyes that had IVFA, 10 (38.5%) had abnormal findings: Seven eyes (26.9%) had peripheral ischemia, 2 (7.7%) had previous peripheral laser scarring, and 2 (7.7%) had active peripheral neovascularization. Three eyes with normal examination results were found to have mild ischemia by IVFA. Patients with ischemia confirmed by IVFA were treated with laser photocoagulation. During follow-up, 4 previously treated eyes received additional laser photocoagulation. No patients showed vision loss, vitreous hemorrhage, retinal detachment, or adverse effects of treatment. No patients required vitreoretinal surgery.
IP is a potentially blinding disease. Our case series demonstrates the efficacy of early treatment and the importance of ancillary testing with IVFA and fundus photography.
本病例系列描述色素失禁症(IP)患者视网膜表现的性质和频率。
这是一项回顾性单中心病例系列研究,纳入了2016年5月至2019年4月期间就诊于联合视网膜顾问公司(亚利桑那州凤凰城)的所有已知IP患者。纳入了14例经皮肤科诊断为IP的患者的28只眼(n = 28)。大多数患者在麻醉下接受检查,并进行了眼底照相和静脉荧光素血管造影(IVFA)。
在28只眼中,8只(28.6%)在眼底检查时有异常视网膜表现。在进行IVFA的26只眼中,10只(38.5%)有异常表现:7只眼(26.9%)有周边缺血,2只眼(7.7%)有既往周边激光瘢痕,2只眼(7.7%)有活动性周边新生血管形成。3只检查结果正常的眼经IVFA发现有轻度缺血。经IVFA确诊为缺血的患者接受了激光光凝治疗。在随访期间,4只先前接受治疗的眼接受了额外的激光光凝治疗。没有患者出现视力丧失、玻璃体积血、视网膜脱离或治疗不良反应。没有患者需要进行玻璃体视网膜手术。
IP是一种潜在致盲性疾病。我们的病例系列证明了早期治疗的有效性以及IVFA和眼底照相辅助检查的重要性。